ARTICLE | Company News
Shire seeks Vpriv approval in Japan
January 15, 2014 2:03 AM UTC
Shire plc (LSE:SHP; NASDAQ:SHPG) disclosed at the JPMorgan Healthcare Conference on Tuesday that it submitted a regulatory application in Japan for Vpriv velaglucerase alfa to treat Gaucher's disease....